相似文献
1
The new genetics of chronic neutrophilic leukemia and atypical CML: implications for diagnosis and treatment.
Blood. 2013 Sep 5;122(10):1707-11. doi: 10.1182/blood-2013-05-500959. Epub 2013 Jul 29.
2
Chronic neutrophilic leukemia and atypical chronic myeloid leukemia: 2024 update on diagnosis, genetics, risk stratification, and management.
Am J Hematol. 2024 Jul;99(7):1360-1387. doi: 10.1002/ajh.27321. Epub 2024 Apr 21.
3
Oncogenic CSF3R mutations in chronic neutrophilic leukemia and atypical CML.
N Engl J Med. 2013 May 9;368(19):1781-90. doi: 10.1056/NEJMoa1214514.
4
CSF3R is mutated in chronic neutrophilic leukemia and atypical CML.
Cancer Discov. 2013 Jul;3(7):OF23. doi: 10.1158/2159-8290.CD-RW2013-104. Epub 2013 May 16.
5
CSF3R mutated myeloid neoplasms: Beyond chronic neutrophilic leukemia.
Hum Pathol. 2024 Jul;149:66-74. doi: 10.1016/j.humpath.2024.06.008. Epub 2024 Jun 13.
6
What's different about atypical CML and chronic neutrophilic leukemia?
Hematology Am Soc Hematol Educ Program. 2015;2015:264-71. doi: 10.1182/asheducation-2015.1.264.
7
Recent Progress in Chronic Neutrophilic Leukemia and Atypical Chronic Myeloid Leukemia.
Curr Hematol Malig Rep. 2017 Oct;12(5):432-441. doi: 10.1007/s11899-017-0413-y.
8
Genomics of chronic neutrophilic leukemia.
Blood. 2017 Feb 9;129(6):715-722. doi: 10.1182/blood-2016-10-695981. Epub 2016 Dec 27.
9
Analysis of CSF3R mutations in atypical chronic myeloid leukemia and other myeloid malignancies.
Ann Diagn Pathol. 2024 Aug;71:152317. doi: 10.1016/j.anndiagpath.2024.152317. Epub 2024 Apr 18.
10
[Molecular characterization of atypical chronic myeloid leukemia and chronic neutrophilic leukemia].
Med Clin (Barc). 2015 Jun 8;144(11):487-90. doi: 10.1016/j.medcli.2014.03.020. Epub 2014 May 20.
引用本文的文献
1
Comprehensive analysis of Atypical chronic myeloid leukemia (aCML): Epidemiology, clinical features, and survival outcomes based on SEER database insights.
Leuk Res Rep. 2025 Feb 17;23:100505. doi: 10.1016/j.lrr.2025.100505. eCollection 2025.
2
Distribution of different classes of CSF3R mutations and co-mutational pattern in 360 myeloid neoplasia.
Ann Hematol. 2025 Jan;104(1):263-274. doi: 10.1007/s00277-025-06232-1. Epub 2025 Feb 5.
3
Chronic Neutrophilic Leukemia: Advances in Diagnosis, Genetic Insights, and Management Strategies.
Cancers (Basel). 2025 Jan 12;17(2):227. doi: 10.3390/cancers17020227.
4
Atypical CML: diagnosis and treatment.
Hematology Am Soc Hematol Educ Program. 2023 Dec 8;2023(1):476-482. doi: 10.1182/hematology.2023000448.
5
Research progress of additional pathogenic mutations in chronic neutrophilic leukemia.
Ann Hematol. 2024 Aug;103(8):2591-2600. doi: 10.1007/s00277-023-05550-6. Epub 2023 Nov 22.
6
Should we move to a genomic classification of neutrophilic myeloid neoplasms?
Blood Adv. 2023 Nov 14;7(21):6705-6706. doi: 10.1182/bloodadvances.2023011103.
7
Characteristics and survival outcomes of patients with atypical chronic myeloid leukemia in the United States: A SEER-based analysis.
Leuk Res Rep. 2023 Aug 6;20:100383. doi: 10.1016/j.lrr.2023.100383. eCollection 2023.
8
Differential diagnoses and the mutational landscape of myelodysplastic/myeloproliferative neoplasm with neutrophilia: A case report.
Mol Clin Oncol. 2023 Jun 28;19(2):62. doi: 10.3892/mco.2023.2658. eCollection 2023 Aug.
9
Chronic neutrophilic leukemia preceded by myelodysplastic syndromes.
Int J Hematol. 2023 Nov;118(5):636-641. doi: 10.1007/s12185-023-03636-5. Epub 2023 Jul 13.
10
Myelodysplastic Syndromes/Myeloproliferative Overlap Neoplasms and Differential Diagnosis in the WHO and ICC 2022 Era: A Focused Review.
Cancers (Basel). 2023 Jun 13;15(12):3175. doi: 10.3390/cancers15123175.
本文引用的文献
1
Oncogenic CSF3R mutations in chronic neutrophilic leukemia and atypical CML.
N Engl J Med. 2013 May 9;368(19):1781-90. doi: 10.1056/NEJMoa1214514.
2
SETBP1 mutations in 415 patients with primary myelofibrosis or chronic myelomonocytic leukemia: independent prognostic impact in CMML.
Leukemia. 2013 Oct;27(10):2100-2. doi: 10.1038/leu.2013.97. Epub 2013 Apr 5.
3
SETBP1 mutations in 658 patients with myelodysplastic syndromes, chronic myelomonocytic leukemia and secondary acute myeloid leukemias.
Leukemia. 2013 Jun;27(6):1401-3. doi: 10.1038/leu.2013.35. Epub 2013 Feb 5.
4
Presence of the JAK2 V617F mutation in a patient with chronic neutrophilic leukemia and effective response to interferon α-2b.
Acta Haematol. 2013;130(1):44-6. doi: 10.1159/000345851. Epub 2013 Feb 7.
5
Recurrent SETBP1 mutations in atypical chronic myeloid leukemia.
Nat Genet. 2013 Jan;45(1):18-24. doi: 10.1038/ng.2495. Epub 2012 Dec 9.
6
Sequential gain of mutations in severe congenital neutropenia progressing to acute myeloid leukemia.
Blood. 2012 May 31;119(22):5071-7. doi: 10.1182/blood-2012-01-406116. Epub 2012 Feb 27.
7
De novo mutations of SETBP1 cause Schinzel-Giedion syndrome.
Nat Genet. 2010 Jun;42(6):483-5. doi: 10.1038/ng.581. Epub 2010 May 2.
8
SETBP1 overexpression is a novel leukemogenic mechanism that predicts adverse outcome in elderly patients with acute myeloid leukemia.
Blood. 2010 Jan 21;115(3):615-25. doi: 10.1182/blood-2009-06-227363. Epub 2009 Nov 16.
9
Identification of risk factors in atypical chronic myeloid leukemia.
Haematologica. 2006 Nov;91(11):1566-8. Epub 2006 Oct 17.
10
Incidence of CSF3R mutations in severe congenital neutropenia and relevance for leukemogenesis: Results of a long-term survey.
Blood. 2007 Jan 1;109(1):93-9. doi: 10.1182/blood-2006-02-004275. Epub 2006 Sep 19.
Zotero 插件